Endura Therapeutics is pioneering the development of RNA-targeting drugs using a novel approach called Enduring Chemistry, which forms covalent bonds with small molecules to block disease-causing proteins
Endura Therapeutics is pioneering the development of RNA-targeting drugs using a novel approach called Enduring Chemistry, which forms covalent bonds with small molecules to block disease-causing proteins. Their platform leverages next-generation sequencing to create detailed interaction maps of RNA targets.